CIK 0001601830
- Large accelerated filer
RECURSION PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- RXRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464099738
- Phone
- +1 385-269-0203
- Business address
- 41S RIO GRANDE STREET, SALT LAKE CITY, UT, 84101
- Former names
- Recursion Pharmaceuticals, LLC
- 4 Shares withheld for taxes Chief Financial Officer gave up 48,028 shares (to pay taxes)
- 4 Planned sale Director sold 40,000 shares at $3.10 ($124,000)
- 4 Planned sale Director sold 30,000 shares at $3.10 ($93,000)
- 4 Grant or award Director acquired 4,902 shares (grant or award)
- 4 Grant or award Director acquired 3,268 shares (grant or award)
- 4 Planned sale Director sold 40,000 shares at $3.25 ($130,000)
- 4 Planned sale Chief Financial Officer sold 7,956 shares at $3.39 ($26,971)
- 4 Conversion Director acquired 20,000 shares (conversion)
- 4 Planned sale CEO and President sold 28,298 shares at $3.35 ($94,660)
- 4 Planned sale Director sold 170,000 shares at $3.46 ($588,200)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 11,908 shares (to pay taxes)
- 4 Planned sale Director sold 40,000 shares at $3.46 ($138,400)
- 4 Planned sale Chief Financial Officer sold 13,426 shares at $3.08 ($41,352)
- 4 Shares withheld for taxes CEO and President gave up 14,280 shares (to pay taxes)
- 4 Shares withheld for taxes CEO and President gave up 10,364 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 11,400 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 11,400 shares (to pay taxes)
- 4 Planned sale Director sold 40,000 shares at $4.12 ($164,800)
- 4 Planned sale Director sold 220,000 shares at $4.20 ($924,000)
- 4 Planned sale Director sold 40,000 shares at $4.47 ($178,800)
Page 3 of 26 · 512 filings